Estrella ImmunopharmaESLA
13F holders, Q2 2024 (June 30)7holders +1
3new positions
2sold out
$1.05avg. 13F price*
At the end of Q2 2024, 7 institutions reported holding Estrella Immunopharma Inc. (ESLA) in their 13F filings, up 1 from Q1 2024. 3 opened new positions and 2 sold out. The largest holders were Geode Capital Management, LLC ($61K), Atw Spac Management LLC ($42K) and MASO CAPITAL PARTNERS Ltd ($11K).
- Company
- Estrella Immunopharma Inc.
- CUSIP
- 297584104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $8K |
| Exits | 2 | $27K |
All 13F filers, Q1 2024 → Q2 2024: 9,252 shares bought and 21,432 shares sold, net −12,180 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 7 holders
| Geode Capital Management, LLC | 0.00% | No change | 58,214 | $61K |
| Atw Spac Management LLC | 0.05% | No change | 40,000 | $42K |
| MASO CAPITAL PARTNERS Ltd | 0.01% | No change | 10,000 | $11K |
| BlackRock Inc. | 0.00% | New | 7,568 | $8K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +28.4% | 7,151 | $8K |
| Bank of America Corp. | 0.00% | New | 78 | $82 |
| JPMorgan Chase & Co. | 0.00% | New | 26 | $27 |
"% of holder's portfolio" is ESLA's weight in each manager's 13F, not the share of Estrella Immunopharma Inc. the manager owns.